CXCL13 has also been shown to be important in SLE; systemic levels of CXCL13 positively correlate with disease activity scores in SLE patients, and blocking CXCL13 in lupus mice attenuated renal disease (15–17). This evidence concerns the gene CXCL13 and kidney disorder.